Endoplasmic reticulum (ER) stress, an adaptive, also termed the unfolded protein response (UPR), is an evolutionarily conserved response. It consists of three main signaling pathways: 1) inositol-requiring protein (IRE1) activation, 2) protein kinase RNA (PKR)-like ER kinase (PERK) activation, and 3) the activation of transcription factor-6 (ATF6) 1 . When adaptation to restore homeostasis fails, ER stress-initiated pathways lead to cellular dysfunction and death 2 . Recent evidence shows that activation of the ER stress response by tradiational risk factos contributes to the pathogenesis of cardiovascular diseases 3, 4 . These studies show that patients and animals with diabetes or hypertension have micro-and macro-vascular complications associated with ER stress induction [5] [6] [7] [8] . Although these findings show that alleviating ER stress had beneficial consequences in the vasculature, the mechanism by which ER stress mediates vascular dysfunction are not completely understood.
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MicroRNAs (miRs) regulate the ER stress response, either through specific targets or through mechanisms that are yet unclear 9 . MiR-204 was recently implicated in ER stress responsive gene modulation and apoptosis in tumorigenesis 10 . Additionally, miR-211, which shares an almost identical sequence with miR-204, is induced in a PERK-dependent manner 11 . Despite these findings, whether miR-204 leads to vascular dysfunction in an ER stress-dependent manner is not known.
MiR-204 is expressed in vascular cells [12] [13] [14] [15] . One of the many targets of miR-204 is the Sirtuin1 lysine deacetylase (Sirt1) 15, 16 . Sirt1 plays vital roles in angiogenensis 17 , endothelium-dependent vasorelaxation 18 , and protects against experimental atherosclerosis 19 . Sirt1 also mitigates endothelial oxidative stress and apoptosis 20, 21 . Furthermore, Sirt1 exerts at least some of its anti-atherosclerotic effect by inhibiting VSMC hypertrophy 22, 23 . However, the relationship between miR-204 and Sirt1 in the context of endothelial dysfunction triggered by ER Immunoblots (B) and immunofluorescence with quantification (C) for ER stress markers in HUVECs treated with tunicamycin (Tunica, 1 μg/ml for 6 h) and transfected with miR-204 I. Tudca (500 μg/ml for 6 h) was used as an ER stress inhibitor. Data is representative of three independent experiments. Control cells were transfected with miR SC and treated with vehicle (Veh). Values expressed relative to miR SC + Veh. *p < 0.05 vs miR SC + Veh, Tudca + Tunica, and miR-204 I + Tunica. #p < 0.05 vs miR SC + Veh. (D) miR-204 is induced by ER stress in endothelial cells. MiR-204 expression quantified by qPCR in HUVECs treated with Tunica or Tudca and transfected with either miR SC or miR-204 I. MiR-204 expression is normalized to GAPDH and expressed relative to miR SC + Veh. n = 3, *p < 0.05 vs miR SC + Veh, Tudca + Tunica, and miR-204 I + Tunica. @p < 0.05 vs miR SC + Veh, and miR-204 I + Tunica. #p < 0.05 vs miR SC + Veh. (E-H) Inhibition of miR-204 suppresses tunicamycin-induced ER stress. mRNA expression of ER stress markers quantified by qPCR in HUVEC transfected with miR204 I and treated with Tunica. Values are normalized to GAPDH and expressed relative to miR SC + Veh. n = 3. *p < 0.05 vs miR SC + Veh, Tudca + Tunica, and miR-204 I + Tunica. @p < 0.05 vs miR SC + Veh, and miR-204 I + Tunica. #p < 0.05 vs miR SC + Veh.
was also suppressed by miR-204 I (Supplementary Fig. 2A-E) . Thus, miR-204 is upregulated by external triggers of ER stress, and is required for the ER stress response in endothelial cells in vitro.
MiR-204 mediates ER stress-induced vascular endothelial dysfunction. We next determined if miR-204 is responsible for vascular endothelial dysfunction secondary to ER stress. We chose impairment of endothelium-dependent vasorelaxation as a marker of endothelial dysfunction. Mice were systemically infused with miR-204 I or a scrambled oligonucleotide and injected with tunicamycin. Treatment with tunicamycin led to impairment of endothelium-dependent relaxation ( Fig. 2A,B) , upregulation of miR-204 (Fig. 2C,D,F) , and ER stress ( Fig. 2E,G; Supplementary Fig. 3E ) in aortas and mesenteric resistance arteries (MRAs). Systemic infusion of miR-204 I protected mice from tunicamycin-induced endothelial dysfunction ( Fig. 2A,B) , suppressed tunicamycin-induced vascular miR-204 (Fig. 2C,D,F) , and mitigated tunicamycin-induced vascular ER stress ( Fig. 2E,G; Supplementary Fig. 3E ). The contractile response to phenylephrine ( Supplementary Fig. 3A ,C) and endothelial-independent relaxation to sodium nitroprusside ( Supplementary Fig. 3B,D) were similar among groups. Therefore, vascular miR-204 is upregulated with ER stress in vivo, and mediates ER stress-induced endothelial dysfunction.
Downregulation of Sirt1 promotes endothelial ER stress.
We then inquired into the relationship between miR-204 and Sirt1 in the context of ER stress. We first investigated if Sirt1, independent of miR-204, regulates endothelial ER stress pathways. Short interfering RNA-mediated knockdown Sirt1 in HUVECs promoted Supplementary Fig. 4A ,B,D,F and H), and in mouse aortas and MRAs ( Fig. 3D-F) . Because miR-204 is in intron 6 of the TRPM3 gene, and is co-transcribed with TRPM3, we also measured TRPM3 expression. Paralleling miR-204 expression, TRPM3 was also upregulated in HUVECs treated with tunicamycin ( Supplementary Fig. 4I ). Thus, endogenous Sirt1 plays an important role in suppressing endothelial miR-204 and ER stress.
Overexpression of Sirt1 inhibits endothelial ER stress. We next asked if Sirt1 overexpression suppresses endothelial ER stress. Overexpression of Sirt1 (lacking the 3′-UTR) in HUVECs using a recombinant adenovirus (Ad Sirt1) inhibited tunicamycin-induced ER stress ( Fig. 3B ; Supplementary Fig. 4B ,F and G), and suppressed tunicamycin-induced miR-204 and TRPM3 expression (Supplementary Fig. 4H and I). To further investigate whether the protection from ER stress conferred by Sirt1 is specific to tunicamycin, we examined the effect of Sirt1 on thapsigargin-induced ER stress. Sirt1 overexpression in HUVECs suppressed ER stress induced by thapsigargin ( Supplementary Fig. 5A -E). Furthermore, overexpression of Sirt1 inhibits endothelial ER stress induced by transfection of miR-204 mimic ( Fig. 3C ; Supplementary Fig. 4C ,J and K). Importantly, overexpression of Sirt1 did not alter total (exogenous mimic plus endogenous) miR-204 ( Supplementary Fig. 4L ). These findings show that ER stress downregulates endothelial Sirt1, and restoring Sirt1 suppresses ER stress triggered by external stimuli as well as by overexpression of miR-204. Conditional deletion of endothelial Sirt1 in mice promotes ER stress and endothelial dysfunction through miR-204. To further understand the relationship between endothelial Sirt1 and miR-204 as it applies to vascular ER stress, we generated mice with conditional deletion of endothelial Sirt1 by crossing Sirt1 flx/flx mice with cadherin-5-Cre mice (EC Sirt1 −/− ; Fig. 4H ). Compared with Sirt1 flx/flx mice, these mice have impaired endothelium-dependent vasorelaxation in both their aortas and MRAs, and this impairment was exacerbated by treatment with tunicamycin (Fig. 4A,D) . In addition, EC Sirt1 −/− mice have elevated miR-204 and TRPM3 in aortas and MRAs compared with Sirt1 flx/flx mice (Fig. 4B ,C,E, and F). In situ hybridization and immunohistochemistry showed upregulation of miR-204 and ER stress markers throughout the thickness of the vessel wall, including the endothelium (Fig. 4G,I ). Moreover, in addition to basal upregulation of miR-204 and ER stress, arteries of EC Sirt1 −/− showed exaggerated induction of miR-204 and ER stress markers (Fig. 4G,I ), and downregulation of vascular Sirt1 (Fig. 4H) , in response to tunicamycin treatment.
We then investigated if miR-204 is obligatory for vascular ER stress and endothelial dysfunction in EC Sirt1
−/− mice. We performed ex vivo transfections of thoracic aortas and MRAs isolated from EC Sirt1 −/− mice with miR-204 I, which resulted in downregulation of miR-204 (Fig. 5A,D) , suppression of ER stress (Fig. 5B,E) , and rescue of endothelium-dependent vasorelaxation (Fig. 5C,F) . Collectively, these findings illustrate that endothelial Sirt1 protects the vasculature from ER stress and maintains vascular homeostasis by curtailing miR-204 expression.
MiR-204 is required for ER stress-induced reactive oxygen species. Change in the redox state with ER stress is well-documented 24, 25 . ER stress increases reactive oxygen species (ROS) leading to oxidative stress 26, 27 . We investigated if miR-204 mediates ER stress-induced ROS. We first determined the effect of miR-204 antagonism on tunicamycin-stimulated 8-hydroxydeoxyguanosine (8-OHDG), an oxidative adduct of DNA. Compared with mice infused with scrambled oligonucleotide, infusion of miR-204 I decreased 8-OHDG in MRAs of tunicamycin-treated mice (Fig. 6A ). In addition, both basal and tunicamycin-stimulated 8-OHDG was upregulated in MRAs of EC Sirt1
−/− mice comparted with EC Sirt1 flx/flx mice (Fig. 6B) . These findings identify an important role for miR-204 in promoting, and endothelial Sirt1 in suppressing, ER stress-induced vascular/ endothelial ROS.
MiR-204 regulates western diet-stimulated vascular ER stress and endothelial dysfunction. To put our findings into a more physiological context, we inquired into the relationship between vascular miR-204 and ER stress in the setting of diet-induced obesity, a condition associated with vascular endothelial dysfunction. ER stress was induced in aortas of mice fed a western high-fat diet (Fig. 7) . This increase was significantly lower in mice systemically infused with miR-204 I compared with those infused with scrambled oligonucleotide (Fig. 7) . Thus, miR-204 is responsible for vascular ER stress in diet-induced obesity, a condition that is associated with vascular endothelial dysfunction.
Discussion
Our findings add to the growing appreciation of the role of miR-204 in ER stress in general, and vascular ER stress in particular. Prior studies have shown that miR-204 promotes vascular ER stress by downregulating endothelial Caveolin-1, and Sirt1 protects Caveolin-1 from miR-204-mediated downregulation 28, 29 . The present study goes further by demonstrating that miR-204-mediated vascular ER stress is also due to downregulation of Sirt1. It also corroborates prior work, demonstrating crosstalk between miR-204 and Sirt1, by showing that miR-204 promotes ER stress by targeting Sirt1, while Sirt1 suppresses ER stress by downregulating miR-204. While Sirt1 may suppress endothelial ER stress through molecular mechanisms described in other tissues and cell types, such as in the liver and hepatoma cells 30, 31 , Sirt1-dependent downregulation of miR-204 may represent an additional mechanism by which it inhibits ER stress.
How precisely Sirt1 controls expression of miR-204, and whether this control involves transcriptional or epigenetic regulation of miR-204 (transcribed from the TRPM3 locus) or through indirect mechanisms, is not clear. However, it is worth noting that thapsigargin-induced upregulation of miR-211, a closely related microRNA which differs from miR-204 by only one nucleotide but shares the same seed sequence (UUUCCCU), in mouse embryonic fibroblasts is dependent on PERK 32 . Moreover, Sirt1 inhibits the PERK/elF2α arm of the ER stress response 33 . These findings, taken together, raise the possibility that Sirt1-dependent inhibition of PERK may contribute to mitigation of miR-204 induction by ER stress in endothelial cells. Regardless of the mechanism, these findings paint a feed forward relationship in which downregulation of Sirt1 by miR-204 during ER stress contributes to amplification of miR-204, and miR-204 promotes ER stress by targeting Sirt1 (Supplementary Fig. 6) .
A prior studiy showed that miR-204 promotes ER stress in pancreatic beta-cells 11 . Furthermore, both miR-204 and miR-211, which is encoded in the TRPM1 gene and transcribed independently from miR-204, are upregulated with thapsigargin and low glucose-stimulated ER stress in mouse embryonic fibroblasts 34 . Although the functional significance and targets of miR-204 upregulation in fibroblasts was not explored, miR-211 downregulated the ER stress protein CHOP by an unusual mechanism involving transcriptional repression of the CHOP promoter, thereby functioning as a pro-survival microRNA during ER stress. While we did not measure miR-211, or examine its role in endothelial ER stress, the above-mentioned mechanism could be operative in endothelial cells as well, and may counteract the role of miR-204 in inducing terminal ER stress.
In summary, this work identifies a novel interactome involving Sirt1 and miR-204 in the regulation of vascular ER stress and vascular endothelial function. Further, this work provides evidence that miR-204 serves as a conduit through which environmental stressors such as a high-fat diet that lead to ER stress contribute to vascular endothelial dysfunction. While this work was limited to endothelial cells and the vasculature, and was focused exclusively on ER stress, the relationship between miR-204 and Sirt1 described herein may also be relevant in other cell types and tissues that express Sirt1 and miR-204, and may play a part in other fundmental cellular processes such as autophagy which are regulated by both Sirt1 and miR-204 29, 35 .
SCIentIfIC In vivo induction of ER stress by tunicamycin. Tunicamycin (Calbiochem, San Diego, CA USA) was dissolve in dimethyl sulfoxide (DMSO) and was injected intraperitoneally at a dose of 0.75 mg/kg, two injections per week for 2 weeks, into mice as previously described 36 . DMSO vehicle was used in control mice.
HFD (Western diet)-induced model of endothelial dysfunction.
Mice were fed a HFD (Envigo, TD.88137) for 8 weeks. Mice fed a normal diet (ND) were used as controls.
In vivo inhibition of miR-204. Locked nucleic acid miR-204 inhibitor (5′-AGG ATG ACA AAG GGA-3′) or a scrambled nucleotide (5′-ACG TCT ATA CGC CCA-3′) (Ambion Life Technologies, Grand Island, NY, USA) was infused into mice using ALZET osmotic mini-pumps that were implanted subcutaneously in mice. Mice treated with tunicamycin were infused with miR-204 inhibitor or scrambled nucleotide for 2 weeks (0.2 mg/week/mouse). HFD and ND fed mice were infused with miR-204 inhibitor or scrambled nucleotide for 6 weeks (0.7 mg/kg/day). SCIentIfIC REpoRtS | 7: 9308 | DOI:10.1038/s41598-017-06721-y stirrups in a 5 mL chamber of a four-chamber myograph system (DMT). One stirrup was connected to a threedimensional micromanipulator and the other to a force transducer. The contractile force was recorded electronically. All rings were stretched to 2000 mg in 500 mg increments over a 1 h period to optimize the contractile response to KCl. One dose of KCl (60 mM) was added to verify vascular smooth muscle viability. Cumulative dose-response curve to phenylephrine (PE) (10 −9 to 10 −5 M) was obtained by administering the drug in one-half log doses. Endothelium-dependent vasodilatation was determined by generating dose-response curves to acetylcholine (ACh) (10 −9 to 10 −5 M). Vasorelaxation evoked by ACh was expressed as percent of maximal contraction. Endothelium-independent vasodilatation was measured by vasorelaxation evoked by cumulative doses of sodium nitroprusside (SNP) in rings pre-constricted with phenylephrine (10 −6 M) and was also expressed as percent maximal contraction.
Ex vivo infections with adenoviruses and transfections with miR-204 inhibitor.
Immunostaining. Paraffin blocks of aortas and MRAs were de-paraffinized with xylene followed by antigen retrieval by heating in citrate buffer (10 mM). Sections were probed with appropriate primary antibodies. Sirt1 antibody (Santa Cruz Biotech, Dallas, TX), Binding immunoglobulin protein (BIP), and C/EBP homologous protein (CHOP) antibodies (Cell Signaling, Denver, MA, USA), von Willebrand factor antibody and 8-hydroxydeoxyguanosine (8-OHdG) antibodies (Abcam, Cambridge, MA,) were used at a 1:50 to 1:200 dilution followed by a biotinylated secondary antibody for immunofluorescence, or streptavidin peroxidase solution, DAB peroxidase substrate, and hematoxylin counterstain for immunohistochemistry. Sections were digitally imaged with an Olympus BX-61 microscope. Images of vessels and cells were taken at 40 × and 60 × magnification, respectively.
Western blotting.
Immunoblotting was performed on aortic and MRA lysates as previously described 37 . Chemiluminescent signal was developed using the Licor Odyssey Scanner (Lincoln, NE, USA). Bands were quantified using image J.
In situ hybridization (ISH) for miR-204. Aortic and MRA sections were de-paraffinized with xylene, followed by Proteinase K treatment (10 μg/mL for 5 min). ISH buffer (Exiqon, Vedbaek, Denmark; production #90000) was added with miR-204 probe (Exiqon, 5′-Dig-N-AGG CAT AGG ATG ACA AAG GGA A-N-Dig-3′) or with a scrambled miR probe (Exiqon, 5′-Dig-N-GTG TAA CAC GTC TAT ACG CCC A-N-Dig-3′) at 20 nM or 40 nM, and incubated for 72 h at 56 °C. After washing, sections were incubated in blocking solution for 15 min (5 mL PBS + 50 mg BSA + 100 uL Sheep serum + 2.5 uL Tween 20), followed by incubation with anti-DIG-FAB overnight (1:800 in antibody dilution solution). Slides were dipped in a solution containing BCIP/NBT (Roche, 
